Skip to content

The clinical efficacy study of combined the Confluent Points and Collecting Points with Four Finger Groove Points on the Cancer-related anorexia

The clinical efficacy study of combined the Confluent Points and Collecting Points with Four Finger Groove Points on the Cancer-related anorexia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500103191
Enrollment
Unknown
Registered
2025-05-26
Start date
2023-11-23
Completion date
Unknown
Last updated
2025-06-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer-related anorexia

Interventions

Acupuncture group:Acupuncture (Heji acupoint+Sixian acupoint)+placebo
drug group (positive control):Mifepristone acetic acid dispersible tablet (manufacturer: Qingdao Guohai Biopharmaceutical Co., Ltd.), 1 tablet each time, once a day, take continuously for 14 days.
control group (negative control):The patient takes a placebo once a day at 8am for a total of 2 weeks.

Sponsors

Beijing Hospital of Integrated Chinese and Western Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. The patient was diagnosed as malignant tumor by histological cytology; 2. Patients who meet the above diagnostic criteria and have no obvious eating disorders; 3. Age >=18 years old and =3 months; 5. Patients who did not participate in other trials or subjects and did not receive radiotherapy, chemotherapy or surgery during the observation period; 6. KPS score >=30 points; 7. Those who agree to accept the treatment plan of this study and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients who are unable to eat orally, such as dysphagia, parenteral nutrition, and indentation of gastric tubes; 2. Acute or chronic digestive diseases; 3. Complicated with serious heart, brain, lung, liver, kidney, endocrine, blood, immune diseases, end-stage diseases; 4. Patients with long-term coma and lethargy; 5. Alzheimer's disease; 6. Communication difficulties caused by hearing and speech disorders; 7. Use of appetite promoting drugs or treatment in the recent 1 month; 8. Participation in clinical trials of tumor treatment within the recent 1 month may interfere with the conclusions of this study; 9. Non-cancerous anorexia, such as anorexia nervosa related to psychological factors; 10. Patients who are dizzy with needles.

Design outcomes

Primary

MeasureTime frame
The change of appetite score before and after treatment;

Secondary

MeasureTime frame
Changes in body mass index before and after treatment;Changes in nutritional biochemical indices before and after treatment;KPS scores before and after treatment;TCM symptom scores before and after treatment;Quality of survival scores for cancer patients before and after treatment;

Countries

China

Contacts

Public ContactJuhua Yuan

Beijing Hospital of Integrated Chinese and Western Medicine

yuanjuhua1231@126.com+86 159 0108 9526

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026